Smart Technology Facilitated Patient-centered Care for Patients With Pulmonary Thromboembolism

Launched by NAVY GENERAL HOSPITAL, BEIJING · Apr 19, 2024

Keywords

ClinConnect Summary

This clinical trial, titled "Smart Technology Facilitated Patient-centered Care for Patients With Pulmonary Thromboembolism," is looking at how smart technologies, like wearable devices and mobile apps, can help manage a condition called pulmonary thromboembolism (PTE), which is a blockage in the blood vessels of the lungs. The main goal is to see if using a mobile app designed for managing this condition can improve the long-term health outcomes for patients. By doing this, the researchers hope to make it easier for patients to access quality care and improve how PTE is treated overall.

To be part of this study, participants need to be at least 18 years old and currently hospitalized with confirmed PTE, either newly diagnosed or with evidence of a previous case. However, some people will not be eligible, such as those who are pregnant, have serious mental or physical disabilities, or cannot use smart devices. This trial is not yet recruiting participants, but when it starts, those involved can expect to help shape better care for future patients with this condition.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Inpatients aged ≥18 years;
• • （2）PTE confirmed through imaging examinations, meeting at least one of the following criteria: a.Newly diagnosed PTE during the current hospitalization; b. Prior PTE with imaging evidence of residual thrombus.
• • Signed informed consent.
• Exclusion Criteria:
• • Previous PTE combined with CTEPH;
• • Mental retardation or a combination of other serious illnesses that make them incapable of living on their own;
• • Inability to use smartphones, computer tablets and other smart devices;
• • Being pregnant or breastfeeding;
• • Have participated in similar trials or are undergoing other clinical trials.